CU22413A1 - Antitumorigenic composition - Google Patents

Antitumorigenic composition

Info

Publication number
CU22413A1
CU22413A1 CU1994004A CU1994004A CU22413A1 CU 22413 A1 CU22413 A1 CU 22413A1 CU 1994004 A CU1994004 A CU 1994004A CU 1994004 A CU1994004 A CU 1994004A CU 22413 A1 CU22413 A1 CU 22413A1
Authority
CU
Cuba
Prior art keywords
activity
protease
type
alacran
baee
Prior art date
Application number
CU1994004A
Other languages
Spanish (es)
Inventor
Chibas Misael Bordier
Fernandez Milagros Maria Martinez
Suarez Hector Luis Salgado
Perez Guillermo Ubaldo Bory
Berwick Franklyn Perry
Martinez Rafael Granado
Frometa Ramona Capo
Crespo Roberto Alcides Aguirre
Galano Joaquin Guitian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CU1994004A priority Critical patent/CU22413A1/en
Publication of CU22413A1 publication Critical patent/CU22413A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ESTA INVENCION SE RELACIONA CON LAS RAMAS DE LA SALUD HUMANA Y ANIMAL, PARA EL TRATAMIENTO DE VARIOS TIPOS DE NEOPLASIAS. EL OBJETIVO TECNICO DE DICHA SOLUCION ES OBTENER UN PREPARADO FARMACEUTICO A PARTIR DEL ALACRAN (RHOPALURUA JUNCEUS) QUE PRESENTA EFECTO ANTITUMORAL. LA ESENCIA DE LA INVENCION RADICA EN LA PREPARACION DE UN PRODUCTO FARMACEUTICO A PARTIR DEL ALACRAN, QUE TIENE ENTRE SUS COMPONENTES: CONCENTRACION DE PROTEINAS; ACTIVIDAD PROTEOLITICA: ACIDA, NEUTRAL, Y ALCALINA (NEGATIVA): ACTIVIDAD INHIBIDORA DE PROTEASAS: FRENTE A PROTEASA DEL TIPO SERINO 18 UNIDADES BAEE.ML-1; FRENTE A PROTEASA DEL TIPO CISTEINO: 4 UNIDADES BAEE.ML-1; ACTIVIDAD FOSFOLIPASICA TIPO A2: 1, 0,15A10-3; ACTIVIDAD HEMOLITICA (NEGATIVA). DICHO PRODUCTO PUEDE APLICARSE EN LA ESFERA DE LA ELABORACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE DIFERENTES TIPOS DE NEOPLASIAS.\!THIS INVENTION IS RELATED TO THE BRANCHES OF HUMAN AND ANIMAL HEALTH, FOR THE TREATMENT OF SEVERAL TYPES OF NEOPLASMS. THE TECHNICAL OBJECTIVE OF SUCH SOLUTION IS TO OBTAIN A PHARMACEUTICAL PREPARATION FROM THE ALACRAN (RHOPALURUA JUNCEUS) THAT PRESENTS ANTI-TUMORAL EFFECT. THE ESSENCE OF THE INVENTION IS IN THE PREPARATION OF A PHARMACEUTICAL PRODUCT FROM ALACRAN, WHICH HAS BETWEEN ITS COMPONENTS: PROTEIN CONCENTRATION; PROTEOLYTIC ACTIVITY: ACID, NEUTRAL, AND ALKALINE (NEGATIVE): PROTEASE INHIBITING ACTIVITY: AGAINST SERINE TYPE PROTEASE 18 UNITS BAEE.ML-1; IN FRONT OF PROTEASE OF THE CYSTEINE TYPE: 4 UNITS BAEE.ML-1; PHOSPHOLIPASIC ACTIVITY TYPE A2: 1, 0.15A10-3; HEMOLYTIC ACTIVITY (NEGATIVE). SUCH PRODUCT MAY BE APPLIED IN THE FIELD OF PREPARING MEDICINES FOR THE TREATMENT OF DIFFERENT TYPES OF NEOPLASMS. \!

CU1994004A 1994-01-11 1994-01-11 Antitumorigenic composition CU22413A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU1994004A CU22413A1 (en) 1994-01-11 1994-01-11 Antitumorigenic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1994004A CU22413A1 (en) 1994-01-11 1994-01-11 Antitumorigenic composition

Publications (1)

Publication Number Publication Date
CU22413A1 true CU22413A1 (en) 1996-01-31

Family

ID=5459147

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1994004A CU22413A1 (en) 1994-01-11 1994-01-11 Antitumorigenic composition

Country Status (1)

Country Link
CU (1) CU22413A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012041261A2 (en) 2010-09-27 2012-04-05 Grupo Empresarial De Producciones Biofarmaceuticas Y Quimicas Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012041261A2 (en) 2010-09-27 2012-04-05 Grupo Empresarial De Producciones Biofarmaceuticas Y Quimicas Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition

Similar Documents

Publication Publication Date Title
HUP0303817A2 (en) Medium-chain length fatty acids, glycerides and analogues as neutrophile survival and activation factors and pharmaceutical compositions containing them
ATE409176T1 (en) 1-PHENYLALKANECARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
CN105671018A (en) Eggshell membrane solubilization method using enzymes
BG105588A (en) Anthranilic acide amides and the use thereof as medicaments
ES2190653T3 (en) Reaction products of hyaluronic acid and amino NATURAL and their use in cosmetic and pharmaceutical compositions.
CN101553202A (en) Mild composition for skin disinfection
FR2453650A1 (en) MEDICAMENT BASED ON CHOLECALCIFEROL DERIVATIVES, USEFUL FOR ADJUSTING BONE METABOLISM IN HOMEOTHERMES
DE602004016403D1 (en) Topical pharmaceutical compositions containing active natural ingredients for the prevention and treatment of mucosal inflammatory processes
CN103463967A (en) Special-purpose formaldehyde scavenging agent for air purifier
ATE340561T1 (en) USE OF ANTISEPTICS FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE PROPHYLAXIS AND TREATMENT OF INFLAMMATION INSIDE THE HUMAN BODY
BRPI0408299A (en) cathepsin inhibitors s
CN103478177A (en) Air disinfectant
TR200100637T2 (en) New natural product derivatives
MY126358A (en) Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs
CU22413A1 (en) Antitumorigenic composition
CU22414A1 (en) Fungicide composition
ATE390121T1 (en) MICELLE COMPOSITIONS CONTAINING PEGYLATED PHOSPHOLIPIDES AND A PHOTOSENSITISER
ATE408619T1 (en) LH-RH ANTAGONISTS, THEIR PRODUCTION AND USE AS MEDICINAL PRODUCTS
ID26240A (en) FORMULATION OF SOLID HALF DRUGS CONTAINING TROMETAMOL DEXSTOPROFENES
ATE548048T1 (en) ONCOMODULIN FOR THE TREATMENT OF NEUROLOGICAL DISEASES
ATE371737T1 (en) PROTEAS RESISTANT FLINT ANALOGUE
ES2175582T3 (en) CHROMANS SUBSTITUTED WITH SULFONAMIDE, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL PRODUCT, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
DE60007179D1 (en) Medicines containing pantothenic acid for the treatment of inflammatory joint diseases
AR010950A1 (en) METHODS OF TREATMENT OF DRY AND SPRAY CAPSULES AND PHARMACEUTICAL FORMULATIONS.
DK1497250T3 (en) Hyperforin derivatives, their use and compositions containing them